Canada markets closed

PsyBio Therapeutics Corp. (PSYBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00740.0000 (0.00%)
At close: 12:47PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.0074
Open0.0074
BidN/A x N/A
AskN/A x N/A
Day's Range0.0074 - 0.0074
52 Week Range0.0030 - 0.0322
Volume9,090
Avg. Volume16,002
Market Cap943,110
Beta (5Y Monthly)0.68
PE Ratio (TTM)N/A
EPS (TTM)-0.0200
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    TSX Venture Exchange Stock Maintenance Bulletins

    TSX VENTURE COMPANIES

  • Newsfile

    PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale

    PsyBio continues to develop psycho-targeted, biosynthesized tryptamines and with this authorization becomes the first biotechnology company to obtain government sanctioned, formal, written authorization to manufacture biosynthetic tryptamines including PsyBio-11142 at scale Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - July 21, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company focused upon disco